Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study.
Punjabi S, Cook LJ, Kersey P, Marks R, Cerio R.
Punjabi S, et al.
Int J Dermatol. 2008 Jan;47(1):78-82. doi: 10.1111/j.1365-4632.2007.03363.x.
Int J Dermatol. 2008.
PMID: 18173610
Clinical Trial.
OBJECTIVE: To assess the safety and efficacy of a 0.005% mixture of solasodine glycosides (Zycure) in the treatment of basal cell carcinoma. Design Double-blind, randomized, and vehicle-controlled, parallel group study. ...There were no major treatment-related adver …
OBJECTIVE: To assess the safety and efficacy of a 0.005% mixture of solasodine glycosides (Zycure) in the treatment of basal c …